FDA More Problematic Than Obamacare, Says Acorda CEO
Ron Cohen, CEO of Acorda Therapeutics, says his company's pipeline is full and he is less worried about Obamacare than the FDA.
Disclosure: TheStreet's editorial policy prohibits staff editors and reporters from holding positions in any individual stocks.
